CFF is a non-profit organization that researches and develops novel therapeutics for the treatment of cystic fibrosis disease.
Business Model: Non-Profit
Revenue: $135.6M
Employees: 501-1,000
Address: 4550 Montgomery Ave.
City: Bethesda
State: MD
Zip: 20814
Country: US
CFF is a non-profit organization that researches and develops novel therapeutics for the treatment of cystic fibrosis disease.
Contact Phone:
+13019514422
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2020 | Microbion | Grant | 17.1M |
5/2021 | Splisense | Series B | 0 |
1/2022 | SalioGen Therapeutics | Series B | 0 |
1/2023 | ReCode Therapeutics | Venture Round | 10M |
3/2022 | Eloxx | Grant | 0 |
1/2022 | Feldan Therapeutics | Grant | - |
1/2022 | Peptilogics | Grant | - |
10/2019 | Enterprise Therapeutics | Grant | 7.3M |
4/2022 | Sionna Therapeutics | Series B | 0 |
3/2018 | Laurent Pharmaceuticals | Grant | 2M |
12/2022 | Pulmocide | Series C | 0 |
12/2021 | EnBiotix | Convertible Note | 0 |
5/2021 | Hunterian Medicine | Grant | 300k |
1/2021 | Eloxx | Grant | 2M |
1/2020 | Crestone | Grant | - |
3/2001 | Altus Pharmaceuticals | Grant | 25M |
9/2019 | Eloxx | Grant | 1.6M |
10/2020 | enGene | Grant | - |
2/2021 | Microbion | Grant | 7.4M |
4/2015 | Corbus Pharmaceuticals | Grant | 5M |
5/2021 | Eloxx | Grant | 2.6M |
5/2018 | ICAgen | Grant | 11M |
1/2018 | Synspira | Grant | 3M |
10/2020 | Synspira | Venture Round | 14M |
10/2021 | Armata Pharmaceuticals | Post-IPO Equity | 7M |
1/2021 | Kinnear Pharmaceuticals | Grant | 3M |
11/2017 | Savara Pharmaceuticals | Grant | 5M |
1/2019 | Vast Therapeutics | Series A | 15M |
12/2021 | Pulmocide | Grant | 3.5M |
9/2017 | 4D Molecular Therapeutics | Venture Round | 3M |
10/2019 | Laurent Pharmaceuticals | Grant | 3M |
10/2022 | Carmine Therapeutics | Series A | - |
5/2021 | Metagenomi | Grant | 600k |
1/2019 | Spirovant | Grant | 4.5M |
1/2023 | Gensaic | Grant | 3.5M |
1/2022 | BIOMx | Post-IPO Equity | 0 |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
11/2020 | Calithera Biosciences | Grant | 2.4M |
10/2002 | Corus Pharma | Grant | 1.7M |
3/2019 | Celtaxsys | Grant | 5M |
12/2022 | Aridis Pharmaceuticals | Post-IPO Equity | 4.8M |
7/2016 | Laurent Pharmaceuticals | Grant | 3M |
7/2022 | Destiny Pharma | Grant | - |
1/2017 | Aridis Pharmaceuticals | Grant | 2.9M |
11/2020 | Polyphor | Grant | 3.3M |
6/2022 | Carbon Biosciences | Series A | 0 |
9/2014 | Parion Sciences | Grant | 3M |
12/2018 | Aridis Pharmaceuticals | Grant | 4.6M |
3/2016 | Laurent Pharmaceuticals | Venture Round | - |
3/2017 | Sound Pharmaceuticals | Grant | 1.6M |
10/2018 | Laurent Pharmaceuticals | Venture Round | - |
3/2016 | Laurent Pharmaceuticals | Funding Round | - |
2/2023 | BIOMx | Post-IPO Equity | 0 |
3/2022 | Felix Biotechnology | Grant | - |
7/2022 | Destiny Pharma | Grant | - |
6/2022 | Carbon Biosciences | Series A | 0 |
4/2022 | Sionna Therapeutics | Series B | 0 |
3/2022 | Eloxx | Grant | 0 |
3/2022 | Felix Biotechnology | Grant | - |
1/2022 | Feldan Therapeutics | Grant | - |
1/2022 | SalioGen Therapeutics | Series B | 0 |
1/2022 | Peptilogics | Grant | - |
1/2022 | BIOMx | Post-IPO Equity | 0 |
12/2021 | EnBiotix | Convertible Note | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|